Search for: "Ariad Pharmaceuticals Inc."
Results 81 - 100
of 103
Sort by Relevance
|
Sort by Date
14 Oct 2009, 7:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Angiomax (Bivalirudin) – US: Medicines Company files patent infringement suit against PLIVA, Barr, Teva following Para IV challenge (Patent Docs) (America-Israel Patent Law) (The IP Factor) (GenericsWeb) Humira (Adalimumab) – US: E D Texas find ‘close issue of claim construction’ supports JMOL of no… [read post]
Federal Circuit to consider whether a separate written description requirement exists in section 112
23 Aug 2009, 11:18 am
In an en banc order Friday, the Federal Circuit announced it will rehear Ariad Pharmaceuticals, Inc. v. [read post]
22 Aug 2009, 4:00 am
We'll see what happens.ARIAD Pharmaceuticals, Inc. v. [read post]
21 Aug 2009, 2:50 pm
By Donald Zuhn -- The Court of Appeals for the Federal Circuit today decided that the appeal in Ariad Pharmaceuticals, Inc. v. [read post]
3 Jun 2009, 9:50 pm
By Donald Zuhn -- Yesterday, Ariad Pharmaceuticals filed a petition for a panel rehearing of the decision issued by the Federal Circuit in Ariad Pharmaceuticals, Inc. v. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
1 Jun 2009, 9:58 pm
Ariad Pharmaceuticals, Inc., dealing another blow to Ariad Pharmaceuticals and U.S. [read post]
17 Apr 2009, 12:00 am
Ltd. sues 11 generics companies over Levaquin patents (Law 360) Lexapro (Escitalopram) – Netherlands District court invalidates Lundbeck’s patent EP ‘066 (IPKat) Lexapro (Escitalopram) - Baldwin’s rules explained (The SPC Blog) Lexapro (Escitalopram) – federal district Judge agrees to determine whether Forest Laboratories destroyed key documents (Law 360) Pegasys (PEG interferon alfa 2a) – Roche wins post grant opposition against Wockhardt… [read post]
14 Apr 2009, 9:59 pm
Judge Linn, at least, believes that is a doctrinal mistake, as he expressly stated in a concurring opinion in Ariad Pharmaceuticals, Inc. v. [read post]
12 Apr 2009, 9:52 pm
Noonan -- Biotechnology patent law faces the consequences of two decisions handed down last week by the Federal Circuit: In re Kubin and Ariad Pharmaceuticals, Inc. v. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
6 Apr 2009, 7:15 pm
By Andrew Williams -- On Friday, the Federal Circuit issued its decision in Ariad Pharmaceuticals, Inc. v. [read post]
3 Apr 2009, 9:35 am
By Donald Zuhn -- This morning, the Federal Circuit issued decisions in both In re Kubin and Ariad Pharmaceuticals, Inc. v. [read post]
6 Oct 2008, 6:15 am
Del. has granted Ariad leave for immediate appeal to the CAFC of the adverse summary judgment ruling.The Boston Globe noted: Ariad Pharmaceuticals Inc. of Cambridge said today [Oct. 6] that a federal judge has granted its request to permit an immediate appeal of the court's ruling against Ariad in a patent infringement case.In its summary judgment ruling, the US District Court for the District of Delaware found that the administration of Enbrel, a… [read post]
24 Sep 2008, 4:59 am
ARIAD Pharmaceuticals Inc., Civil Action No. 06-cv-00259 (D. [read post]
22 Sep 2008, 6:41 am
The Boston Globe noted: Ariad Pharmaceuticals Inc. of Cambridge said Sept. 22 that it plans to pursue the "appropriate legal action" after a federal judge ruled against it in a patent dispute.See alsoMore on Ariad/Lilly [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
7 Feb 2008, 8:48 pm
Del.) granted leave to Amgen Inc. to amend and supplement its reply to ARIAD Pharmaceuticals Inc.'s counterclaims to include new claims of inequitable conduct. [read post]
10 Jul 2007, 9:51 pm
By Donald Zuhn -- On Monday, ARIAD Pharmaceuticals, Inc. announced that the U.S. [read post]
